Model with EUROclass | Model with EUROclass and CD8+ HLA-DR+ | Total | |
---|---|---|---|
Predicted probabilities (%) | < 50% | ≥ 50% | |
Patients who experienced CVID complications | |||
< 50% | 9 |
| 19 |
≥ 50% | 1 | 5 | 6 |
Total | 10 | 15 | 25 |
Patients who didn’t experience CVID complications | |||
< 50% | 22 | 5 | 27 |
≥ 50% | 2 | 1 | 3 |
Total | 24 | 6 | 30 |